To further validate the effects of Stat3 on radiotherapy response in HER2-positive breast cancer cells, SKBR3 cells were treated with Stat3 specific inhibitor, S3I-201, before irradiation treatment. This evidence concerns the gene ERBB2 and breast cancer.